Search results
FDA chides Cue Health for changing its home COVID test, tells consumers to throw them out
FierceBiotech· 19 hours agoAccording to the agency, its inspectors discovered that the diagnostics company had made undisclosed changes to its products in the time since receiving a green light from the FDA and that these ...
Earnings call: INOVIO outlines 2024 plans, reports Q1 financials By Investing.com
Investing.com· 1 day agoINOVIO Pharmaceuticals Inc. (NASDAQ: INO), a biotechnology company, has reported its financial...
Future pandemics will have same human causes as ancient outbreaks—lessons from anthropology can...
Medical Xpress· 7 days agoSince 2000, the world has experienced 15 novel Ebola epidemics, the global spread of a 1918-like...
Will the expanded solo traveller scheme be a game-changer for Hong Kong tourism?
South China Morning Post· 4 days agoFirst open to Guangdong cities, namely Dongguan, Zhongshan, Jiangmen and Foshan, the scheme was...
FDA Roundup: May 14, 2024
WPRI Providence· 16 hours agoOn Monday, the FDA's Office of Science and Engineering Laboratories launched an improved online Regulatory Science Tool (RST) Catalog to enhance search and browse capability as well as allow ...
New COVID-19 FLiRT strain detected in Arizona. Here's what you need to know
The Arizona Republic· 7 days agoDavid Engelthaler, who leads the infectious-diseases division of the Arizona-based Translational...
Skirmish over paper drug info draws on
Politico· 18 hours ago“If testing was performed more than two weeks ago, and there is no reason to suspect current SARS-CoV-2 infection, it is not necessary to retest.” The agency issued a warning ...
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
Digital Journal· 14 hours agoPresented data on GEO-CM04S1 at World Vaccine Congress, delineating the unique immune system driven mechanisms that contribute to the broad efficacy of the vaccine candidate Significant milestone ...
Gene therapy trials deliver double win
Nature· 6 days agoFinal results of two studies — whose preliminary data led to regulatory approval of the gene therapy exagamglogene autotemcel — describe highly effective...
Invivyd Inc (IVVD) Reports Q1 2024 Financial Results: A Detailed Analysis
GuruFocus.com via Yahoo Finance· 5 days ago:IVVD), a pioneering biopharmaceutical company, disclosed its financial outcomes for the first quarter ended March 31, 2024, through its 8-K filing. The company, known for its innovative approach ...